Zung N. Do

发表

Pharmacokinetics and Pharmacodynamics of AR9281, an Inhibitor of Soluble Epoxide Hydrolase, in Single‐ and Multiple‐Dose Studies in Healthy Human Subjects

Sampathkumar Anandan, D. Patel, D. Chen, 2012, Journal of clinical pharmacology.

1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia.

Paul D. Jones, B. Hammock, D. Macintyre, 2011, Bioorganic & medicinal chemistry letters.

Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble expoxide hydrolase.

Sampathkumar Anandan, R. Gless, Zung N. Do, 2009, Bioorganic & medicinal chemistry letters.

Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors.

S. Hwang, B. Hammock, C. Morisseau, 2006, Bioorganic & medicinal chemistry letters.

Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors.

Sampathkumar Anandan, D. Patel, R. Gless, 2009, Bioorganic & medicinal chemistry letters.

Characterization of cell lines developed from the glassy-winged sharpshooter, Homalodisca coagulata (hemiptera: Cicadellidae)

B. Hammock, J. Hagler, S. Kamita, 2005, In Vitro Cellular & Developmental Biology - Animal.

Structure-activity relationship for noncoplanar polychlorinated biphenyl congeners toward the ryanodine receptor-Ca2+ channel complex type 1 (RyR1).

T. Albertson, I. Pessah, C. Garner, 2006, Chemical research in toxicology.

Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.

Paul D. Jones, B. Hammock, C. Morisseau, 2006, Bioorganic & medicinal chemistry letters.

1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia.

S. Cases, Sampathkumar Anandan, J. Waszczuk, 2011, Bioorganic & medicinal chemistry letters.